Innovation Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
Innovation Pharmaceuticals has a total shareholder equity of $1.2M and total debt of $695.0K, which brings its debt-to-equity ratio to 59.8%. Its total assets and total liabilities are $6.7M and $5.5M respectively.
Key information
59.8%
Debt to equity ratio
US$695.00k
Debt
| Interest coverage ratio | n/a |
| Cash | US$864.00k |
| Equity | US$1.16m |
| Total liabilities | US$5.51m |
| Total assets | US$6.67m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IPIX's short term assets ($940.0K) do not cover its short term liabilities ($5.0M).
Long Term Liabilities: IPIX's short term assets ($940.0K) exceed its long term liabilities ($457.0K).
Debt to Equity History and Analysis
Debt Level: IPIX has more cash than its total debt.
Reducing Debt: IPIX had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if IPIX has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if IPIX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.